ConductScience.org, home

Paper14484792

The effect of a serotonin antagonist (UML 491) in carcinoid disease.

PEART WS and 1 other. Lancet, 1961. Cited by 51 papers, by iCite.

Cite this record

ConductScience Library. The effect of a serotonin antagonist (UML 491) in carcinoid disease. Papers, record 14484792. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/14484792

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
The effect of a serotonin antagonist (UML 491) in carcinoid disease.
PubMed
Journal
Lancet
PubMed
Year
1961
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
51
iCite
Revised in PubMed
2019-06-12
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1PEART WSW S
2ROBERTSON JIJ I

Source PubMed

Download CSV of authors

Topics5

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Carcinoid TumorMajor topic
Malignant Carcinoid SyndromeMajor topic
MethysergideMajor topic
Serotonin AntagonistsMajor topic
Lysergic Acid Diethylamide

Cited by13

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 51 citations.

PMIDTitleJournalYearIn PapersSource
18668794Motor responses of human gastrointestinal tract to 5-hydroxytryptamine in vivo and in vitro.Gut1966https://conductscience.org/library/papers/18668794PubMed
14479461Effect of methyldopa in carcinoid disease.Br Med J1962https://conductscience.org/library/papers/14479461PubMed
8100206Effects of serotonin on rat ileocolonic transit and fluid transfer in vivo: possible mechanisms of action.Gut1993https://conductscience.org/library/papers/8100206PubMed
6181801Use of arterial devascularization and cytotoxic drugs in 30 patients with the carcinoid syndrome.Br J Cancer1982https://conductscience.org/library/papers/6181801PubMed
6050497Antagonism by methysergide of vascular effects of 5-hydroxytryptamine in man.Br J Pharmacol Chemother1967https://conductscience.org/library/papers/6050497PubMed
6020139The effect of 5-hydroxytryptamine on the human colon in vivo and in vitro.Proc R Soc Med1967https://conductscience.org/library/papers/6020139PubMed
5497834The release of biologically active substances from isolated lungs by 5-hydroxytryptamine and tryptamine.Br J Pharmacol1970https://conductscience.org/library/papers/5497834PubMed
5031235Forgotten bradykinin?Br Med J1972https://conductscience.org/library/papers/5031235PubMed
4333528Diarrhoea: mechanisms and treatment.Gut1971https://conductscience.org/library/papers/4333528PubMed
2285651Carcinoid syndrome and serotonin: therapeutic effects of ketanserin.Cardiovasc Drugs Ther1990https://conductscience.org/library/papers/2285651PubMed
2285645Serotonin and vascular disease: a survey.Cardiovasc Drugs Ther1990https://conductscience.org/library/papers/2285645PubMed
656815Surgical approaches and drug treatment in the carcinoid syndrome.Br Med J1978https://conductscience.org/library/papers/656815PubMed
390899Prostaglandins and serotonin: nonpeptide diarrheogenic hormones.World J Surg1979https://conductscience.org/library/papers/390899PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/14484792

GET https://conductscience.org/api/papers/v1/14484792/authors